THE SCHEDULE 13G

Company

Protara Therapeutics, Inc.

Filed

December 17, 2024

Accession Number

0000921895-24-002967

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →